Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 8, 2010, Pages 1364-1370

  Yan, Yi Dong ^a   Woo, Jong Soo ^a   Kang, Joon Heok ^a   Yong, Chul Soon ^a   Choi, Han Gon ^a  

^a Yeungnam University   (South Korea)

Author keywords

Donepezil hydrochloride; Microsphere; Orally disintegrating tablet; Pharmacokinetics; Taste masking

Indexed keywords

DONEPEZIL; MICROSPHERE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BITTER TASTE; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HUMAN EXPERIMENT; MASKING; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PALATABILITY; PARTICLE SIZE; PROCESS OPTIMIZATION; RAT; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TABLET DISINTEGRATION; TASTE MASKING; TIME TO MAXIMUM PLASMA CONCENTRATION; VISCOSITY; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; INDANS; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; PIPERIDINES; POLYMETHACRYLIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SALIVA; SOLUBILITY; SURFACE PROPERTIES; TABLETS; TASTE; TASTE THRESHOLD; X-RAY DIFFRACTION;

EID: 77956118891     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1364     Document Type: Article

References (27)

1. Bhise K., Shaikh S., Bora D., AAPS Pharm SciTech, 9, 557-562 (2008).
2. Habid W., Khankari R. K., Hontz J., Crit. Rev. Ther. Drug Carrier Sys., 17, 61-72 (2000).
3. Kaushik D., Dureja H., Saini T. R., Indian Drugs-Bombay, 41, 187-193 (2004).
4. Hanawa T., Watanabe A., Tsuchiya T., Ikoma R., Hidaka M., Sugihara M., Chem. Pharm. Bull., 43, 284-288 (1995).
5. Koizumi K., Watanabe Y., Morita K., Utoguchi N., Matsumoto M., Int. J. Pharm., 152, 127-131 (1997).
6. Seager H., J. Pharm. Phamacol., 50, 375-382 (1998).
7. Jianchen X., Li L. B., Kang Z., Int. J. Pharm., 359, 63-69 (2008).
8. Uchida T., Nakamura T., Tanigake A., Chem. Pharm. Bull., 50, 1589-1593 (2002).
9. Schiermeier S., Schmidt P. C., Eur. J. Pharm. Sci., 15, 295-305 (2002).
10. Nanda A., Kandarapu R., Garg S., Indian J. Pharm. Sci., 64, 10-17 (2002).
11. Sohi H., Sultana Y., Khar R. K., Drug Dev. Ind. Pharm., 30, 429-448 (2004).
12. Kajiyama A., Tamura T., Mizumoto T., Kawai H., Takahashi T., U.S. Patent 6656492 (2003).
13. Lu M. Y. F., Borodkin S., Woodward L., Li P., Diesner C., Hernandez L., Vadnere M., Pharm. Res., 8, 706-712 (1991).
14. Borodkin N., Sundberg D. P., J. Pharm. Sci., 60, 1523-1527 (1971).
15. Motola S., Agisim G. R., Mogavero A., U.S. Patent 5024997 (1991).
16. Fernandes C. M., Veiga F. J., Chem. Pharm. Bull., 50, 1597-1602 (2002).
17. Gao Y., Cui F.-D., Guan Y., Yang L., Wang Y.-S., Zhang L.-N., Int. J. Pharm., 318, 62-69 (2006).
18. Khan S., Kataria P., Nakhat P., Yeole P., AAPS PharmSciTech, 8, E1-E7 (2007).
19. Robson H., Craig D. Q. M., Deutsch D., Int. J. Pharm., 201, 211-219 (2000).
20. Hashimoto Y., Tanaka M., Kishimoto H., J. Pharm. Pharmacol., 54,1323 (2002).
21. Bruschia M. L., Cardosoa M. L. C., Lucchesib M. B., Gremiao M. P. D., Int. J. Pharm., 264, 45-55 (2003).
22. Soppimath K. S., Kulkarni A. R., Aminabhavi T. M., J. Microencapsul., 18, 397-409 (2001).
23. Raghavendra C. M., Namdev B. Sh., Ajit P. R., Sangamesh A. P., Tejraj M. A., Carbohydr. Polym., 71, 42-53 (2008).
24. Yoshida T., Tasaki H., Maeda A., Katsuma M., Sakoa K., Uchidac T., Int. J. Pharm., 365, 81-88 (2008).
25. Kosasa T., Kuriya Y., Matsui K., Yamanishi Y., Eur. J. Pharmacol., 389, 173-179 (2001).
26. Horacio P., Romina F., Paula O. V., Marcelo P., Maria T. P., J. Pharm. Biomed. Anal., 27, 177-182 (2002).
27. Society of Toxicology (SOT) www.toxicology.org/AI/FA/guidingprinciples.pdf (1999).